China Pharma Holdings, Inc. (NYSE:CPHI – Get Free Report) saw a large drop in short interest in May. As of May 31st, there was short interest totalling 44,600 shares, a drop of 29.7% from the May 15th total of 63,400 shares. Approximately 2.0% of the company’s stock are sold short. Based on an average daily trading volume, of 82,400 shares, the short-interest ratio is currently 0.5 days.
China Pharma Stock Up 13.3%
Shares of CPHI stock opened at $1.85 on Tuesday. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26. China Pharma has a one year low of $1.20 and a one year high of $3.35. The company’s 50-day moving average is $3.08 and its 200 day moving average is $15.15.
Wall Street Analyst Weigh In
Separately, Wall Street Zen raised China Pharma from a “sell” rating to a “hold” rating in a report on Wednesday, May 21st.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Stories
- Five stocks we like better than China Pharma
- How to Invest in Insurance Companies: A Guide
- New Catalysts to Drive NVIDIA’s Stock Price Even Higher
- Using the MarketBeat Dividend Tax Calculator
- China Market Movers: MCHI, PDD, BIDU Show Bullish Trends
- How to Calculate Inflation Rate
- Palantir Defies Bears, Leads S&P 500 in 2025
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
